July 23, 2014: Johnson & Johnson (NYSE: JNJ ) held a conference call last week to go over the results of its second-quarter financials and give investors a taste of what's to come. Here are three quotes.
July 23, 2014: Despite growing clamor for drug makers and researchers to publish clinical trial results, many studies are not disclosed to the public, according to a new study.
July 23, 2014: When it comes to the highest paid biopharma CEOs, don’t look to any Triangle dinner parties to find one. Although many of the biotechnology or pharmaceutical companies that paid their top executive the most have operations here, none of them have their headquarters here.
July 23, 2014: Galena BioPharma CEO Mark Ahn continues to shell out big money for obsolete, rarely prescribed drug products. Tuesday, Galena entered into a license agreement with MonoSol Rx for Zuplenz.